drugset / Trial / NCT06417229
Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants
RandomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, drug levels, food effects and relative bioavailability of BMS-986365 in healthy male participants.
Timeline
- Start
- 2024-05-28
- Primary completion
- 2025-02-19
- Completion
- 2025-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986365 | Other / unclassified | — | — |
| Subject | Rabeprazole | Small molecule | — | — |
Indications
No indication recorded.